LS-P-TRACE

A Multi-Center, Open-Label, Phase 1/2 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-101 Monotherapy and AB-101 with Immunotherapy in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma of B-Cell Origin. (NCT04673617)